BABA
Alibaba Group Holding Limited
BABA has the edge over WEN overall, supported by stronger modeled upside and lower modeled downside.
WEN
The Wendy's Company
WEN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
WEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
WEN's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
WEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $5.76 | -30% |
| Current | 16x | $8.18 | — |
| Fair | 23x | $11.48 | +40% |
| Expensive | 39x | $19.70 | +141% |
Historical ranges are pointers, not guarantees.
WEN has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
WEN Forward outlook
There aren't enough analyst estimates for WEN to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over WEN on earnings, with more consistent year-over-year improvement.
WEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.51 | -46% |
| Q2 2026 | $0.66 | -31% |
| Q1 2026 | $0.78 | -17% |
| Q4 2025 | $0.85 | -11% |
| Q3 2025 | $0.94 | 0% |
| Q2 2025 | $0.96 | -1% |
| Q1 2025 | $0.94 | -4.1% |
| Q4 2024 | $0.95 | -2.1% |
WEN's earnings per share have fallen from their peak: $0.51 over the past year, against $0.98 in early 2024.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over WEN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
WEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $547M | -0.5% |
| Q2 2026 | $570.6M | +1.7% |
| Q1 2026 | $540.6M | +3.3% |
| Q4 2025 | $543M | -5.5% |
| Q3 2025 | $549.5M | -3% |
| Q2 2025 | $560.9M | -1.7% |
| Q1 2025 | $523.5M | -2.1% |
| Q4 2024 | $574.3M | +6.2% |
WEN's revenue grew through 2022 and has held roughly level since: $547M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -6.6 points |
| Q2 2026 | 14% | -4.7 points |
| Q1 2026 | 12% | -3.9 points |
| Q4 2025 | 12% | -4.9 points |
| Q3 2025 | 17% | 0 points |
| Q2 2025 | 19% | +1.1 points |
| Q1 2025 | 16% | +0.7 points |
| Q4 2024 | 17% | +0.7 points |
WEN has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
WEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.7M | -41% |
| Q2 2026 | $81M | +107% |
| Q1 2026 | $47.5M | -30% |
| Q4 2025 | $31.4M | +18% |
| Q3 2025 | $104.3M | -15% |
| Q2 2025 | $39.2M | +38% |
| Q1 2025 | $67.7M | -18% |
| Q4 2024 | $26.6M | -43% |
WEN has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
WEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +589K shares |
| 1 year | +0.3% | +548K shares |
| 3 years | -8.9% | -18.8M shares |
| 5 years | -15% | -33.3M shares |
| Available history | -18% | -43.3M shares |
WEN has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.9M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $14.3M |
| Q2 2025 | $63.7M |
| Q1 2025 | $122.8M |
| Q4 2024 | $17.3M |
WEN spent $2M buying back its own shares over the past year, down 99% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over WEN on leverage, with a lower net debt burden relative to earnings.
WEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 5.3x | High |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 5.0x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 4.7x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.5x | High |
WEN's net debt is about 5.6 years of its operating earnings (EBITDA), up from 4.7 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
WEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 59.6 | Neutral |
WEN's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
WEN PE vs Consumer Cyclical Sector
| Metric | WEN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 25 | 47 | 22 pts below |
WEN has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
WEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.92 | 18% above |
| 20 week MA | $7.48 | 9.4% above |
| 50 week MA | $7.56 | 8.2% above |
| 100 week MA | $9.77 | 16% below |
| 200 week MA | $14.7 | 44% below |
WEN has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
WEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.2 | $22.5 | +1.3% |
| 2021 | $22.5 | $23.3 | +3.9% |
| 2022 | $23.3 | $23.1 | -0.9% |
| 2023 | $23.1 | $19.5 | -16% |
| 2024 | $19.5 | $16.5 | -15% |
| 2025 | $16.5 | $8.35 | -49% |
| 2026 YTD | $8.35 | $8.18 | -2% |
WEN has the edge over BABA on returns for 2026, with the stronger performance.